A new interim CFO has been appointed at SkinBioTherapeutics plc following the departure of the figure who triggered a probe into the actions of ex-CEO Stuart Ashman. The Newcastle firm, developing gut-based products which promote skin health, was thrown into crisis earlier this year. Emily Bertram, who joined as CFO in 2025, escalated concerns that … Continue reading New CFO at crisis firm SkinBioTherapeutics